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Orange IV stabilizes silk fibroin
microemulsions
Silk fibroin (SF) is a natural biopolymer that has been extensively studied in various
applications due to its impressive mechanical properties and biocompatibility. Re-
cently, SF-based particles have been proposed as controlled drug delivery systems. A
new and efficientmethod to prepare SFmicroemulsions (SF-MEs) was developed by
oil-in-water emulsions using high-pressure homogenization to promote emulsifica-
tion. During SF-ME production, the secondary structure of SF changed to a more
stable conformation (from random coil to β-sheets), thus allowing the formation
of small and stable (140.7 ± 1.9 nm; polydispersity index, 0.25) SF microparticles
(SF-MPs). The efficiency of SF-MP formation was 60%. Orange IV was used as a
model compound for incorporation and release studies, although its incorporation
into the SF-MEs significantly improved particle size and size distribution over at least
4 wk compared to traditional stabilizers (e.g., poloxamer 407, transcutol, Tween 80,
and SDS). This should be a call of attention when using dyes as model compounds
since they can influence particle properties and lead to misinterpretation of the re-
sults. Orange IV showed an incorporation efficiency of 91% and a controlled release
over time. Stable SF-MP formulations, further enhanced by orange IV incorpora-
tion, provide an innovative method with potential application in pharmaceutical
development due to its associated high biocompatibility and release profile.
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1 Introduction
Silk fibroin (SF) is largely exploited as a biomaterial due to its
unique characteristics, namely, strength, excellent biocompat-
ibility, good oxygen permeability, high thermal stability, slow
biodegradation, and minimal inflammatory and immunogenic
response [1–4]. This FDA-approvedbiopolymer [3,5] canbe fur-
ther processed into differentmaterials, such as 3D scaffolds [6,7],
films [7, 8], electrospun fibers [7, 9], and microspheres [7].
The primary structure of SF protein from Bombyx mori
silkworm cocoons is characterized by the sequence [Gly-Ala-
Correspondence: Prof. Artur Cavaco-Paulo (artur@deb.uminho.
pt), Centre of Biological Engineering (CEB), University of Minho,
Campus of Gualtar, 4710-057 Braga, Portugal
Abbreviations: FTIR, FT infrared spectroscopy; HPH, high-pressure
homogenizer; MEs, microemulsions; MPs, microparticles; PDI, poly-
dispersity index; SF, silk fibroin; SF-MEs, silk fibroin microemulsions;
SF-MPs, silk fibroin microparticles
∗Current address: Ana S. Abreu, Institute of Polymers and Composites
(IPC), Institute Nanostructures, Nanomodelling and Nanofabrication
(I3 N), University of Minho, Guimara˜es, Portugal
Gly-Ala-Gly-Ser]n, which folds into a secondary structure of an-
tiparallel β-sheets [10, 11]. The SF stability is mainly dependent
on the β-sheet content and its presence increases the interaction
with different substances for a long period of time. This feature
makes the use of SF suitable for drug delivery purposes [12, 13].
One of the most commonly used methods for the pro-
duction of protein-based particles is emulsification [14–16].
However, emulsions are nonequilibrium and nonspontaneous
systems [17] and, therefore, its production requires a large input
of energy or the addition of surfactants for stabilization [18–20].
Emulsification can be achieved using high-energy methods, in
which intensely disruptive forces break the oil and water phases
creating micro- and nanosized droplets [12, 17]. The high-
energy mechanical devices can be ultrasonicators, high-pressure
homogenizers (HPHs), or microfluidizers [12, 17].
Previously, our research group was able to prepare BSA,
HSA, and SF emulsions by the ultrasonic emulsification method
[21–23]. However, the large dimensions of the resulting SF par-
ticles were inappropriate for drug delivery purposes [21–23]. In
continuity of this work, it was necessary to optimize the emul-
sification process for the production of SF particles suitable for
drug delivery.
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In order to obtain stable particles that maintain their char-
acteristics over time, it is important to choose and optimize the
preparation method, as well as to add stabilizers into the for-
mulation [19]. It is known that stabilizers prevent the system to
revert into a lower-energy configuration of the thermodynamic
equilibrium [19]. Polymeric surfactants are one of the most ef-
fective stabilizers, since they control and prevent flocculation
and coalescence effects to occur [24].
Some of the most common surfactants used are poloxamer
407,Tween80, transcutol, andSDS.Poloxamer 407 andTween80
are nonionic polymeric surfactants composed of poly(ethylene
glycol) and poly(propylene glycol) [24,25], and polyoxyethylene
[20] and sorbitan monooleate [26,27] chains, respectively. SDS,
the most common anionic surfactant, is capable of adsorbing
the oil-droplet surfaces within homogenizers [28]. Similar to
poloxamer 407, SDS acts as a gelling agent by inducing self-
assembly of SF into stableβ-sheet structures [29], and like Tween
80, it possesses an amphipathic structure, also being considered
as a detergent [30]. Transcutol is not only a powerful stabilizing
agent, but it is also a skin penetration enhancer [31], adding an
extra value to cosmetic formulations. This short-chain alcohol
is mainly used as an additive due its weak amphiphilic character,
being considered as a cosurfactant [31–33].
To evaluate the efficiency of the particulate drug delivery sys-
tems, incorporation and release studies can be performed using
dyes as model compounds [34–37]. The use of dyes facilitates
the study of the release profile, as the dye can be qualitatively
(visually) and quantitatively detected [34–37]. For instance, or-
ange IV can be easily quantified by UV-Vis spectrophotometry
at 240 nm [38, 39]. Herein, we present the development of SF
microemulsions (SF-MEs) using anHPH in the absence or pres-
ence of different types of nonionic and neutral surfactants to
enable efficient and safe drug delivery.
2 Materials and methods
2.1 Materials
Cocoons of Bombyx mori silkworms were kindly supplied by the
CRA – Unita´ di Ricerca di Apicoltura e Bachicoltura (Padova,
Italy). All chemical reagents were of analytical grade and were
purchased from Sigma-Aldrich (Spain). The dialysis tubing cel-
lulosemembrane (MWCO,12–14kDa)was fromSigma-Aldrich,
and centrifuge filtration devices Amicon Ultra-15 (MWCO,
3 kDa) were from Millipore Corporation (Ireland).
2.2 Methods
2.2.1 Preparation of regenerated SF
SF stock solutionswere prepared as previously described [40,41].
Briefly, raw silk from the B. mori silkworms cocoons was boiled
three times in an aqueous solution of Na2CO3 (0.05%) for
30 min and washed several times with deionized water for
complete sericin removal. The dried degummed silk was then
dissolved in 9 M lithium bromide (LiBr) for 3 h at 60˚C and,
after filtration, the resulting SF solution was dialyzed in cellulose
tubing (MWCO, 12–14 kDa) against distilled and deionized
water for at least 3 days at room temperature to remove the
neutral salts and LiBr. All impurities were accounted in our
work, as described in the cited procedures [40, 41].
The final solution of SF (termed as regenerated SF, RSF)
was quantified at 595 nm by the Bradford method (Bio-Rad
Laboratories) using SF as a standard protein. The calibration
curve of SF for Bradford quantification (data not shown) was
determined with several concentrations of SF, after weighting
previously prepared and lyophilized SF protein.
2.2.2 Preparation of SF-MEs
SF-MEswere produced in anAPV-2000double-stageHPH(sup-
plied from SPX Flow Technology, APVManufacturing, Poland).
Optimization was done at a preliminary analysis (data not
shown), in which various parameters were evaluated, such as
SF concentration (range 1–10 g/L), oil-in-water ratio (10/90,
20/80, and 40/60), stabilizer concentration (range 0.5-10%
of w/v), and number of homogenising cycles (range 2–28).
The optimized formulations were produced with 80 mL of
10 g/L of regenerated SF containing 1% of w/v of stabiliz-
ers (poloxamer407 (poly[ethylene glycol]-block-poly[propylene
glycol]-block-poly[ethylene glycol], (C3H6O.C2H4O)n), tran-
scutol (di[ethylene glycol]ethyl ether, C6H14O3), Tween 80
(polyoxyethylene 80 sorbitan monooleate, C64H124O26) or SDS
(CH3(CH2)11OSO3Na), and 20 mL of n-dodecane that passed
through two homogenizing devices connected in series, with a
first stage at 580–600 bar and a second stage at 240–250 bar for
22 homogenization cycles.
Also, orange IV (sodium 4-[(E)-[4-(phenylamino)phenyl]
diazeny]benzenesulfonate, C18H14N3NaO3 S) at 1% of w/v was
added to the SF solution (10 g/L). Themixture was gently shaken
until no solid was observed in suspension and the subjected to
homogenization. For incorporation studies, concentrations of
50, 75, and 100 μM of orange IV were used.
2.2.3 Characterization of SF-MEs
2.2.3.1 Structural analysis by FT infrared spectroscopy (FTIR)
The FTIR spectra of the lyophilized SF solution and the pro-
duced SF-MEs were obtained using Jasco FT/IR 4100 spectrom-
eter equipped with attenuated total reflectance accessory. The
infrared spectra were recorded in transmission mode between
600 and 4000 cm–1 by accumulation of 128 scans with a resolu-
tion of 8 cm–1. Gaussian deconvolution of Amide I band region
(wavenumber between 1600 and 1700 cm–1) was analyzed using
OriginPro 8.5 software (OriginLab Corporation, MA, USA).
2.2.3.2 Size and surface charge evaluation
Using the NANO ZS Malvern Zetasizer equipment (Worces-
tershire, UK), SF-MPs were characterized regarding their mean
diameter, size distribution and polydispersity index (PDI) by dy-
namic light scattering, and zeta-potential values by laserDoppler
anemometry. This characterization was performed immediately
after the emulsification process and at different time points over
2–5 wk, the samples having been stored at 4˚C.
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2.2.3.3 SF-MP efficiency of formation
Efficiency of formation of the SF-MPs was determined using
Eq. (1). For that, SF-MEs were centrifuged (10 976 × g, 60
min) in order to separate the free SF protein from the MPs,
the resulting supernatant of each sample being collected and
quantified by Bradford method (n = 3).
Formation Efficiency (%) =
[Protein] initial − [Protein] final
[Protein] final
× 100 (1)
2.2.3.4 Encapsulation efficiency of orange IV into the SF-MPs
Orange IV loaded SF-MPs were centrifuged (5000 × g, 45 min)
using centricon tubes (100 kDa), and the resulting filtrate was
quantified (n = 3) at 240 nm using UV spectrometry and a
calibration curve of orange IV standards (data not shown). The
encapsulation efficiency (%) of orange IV into the MPs was
determined using Eq. (2).
Encapsulation Efficiency (%) =
[
Orange IV
]
initial − [Orange IV] final
[
Orange IV
]
final
× 100 (2)
2.2.3.5 In vitro orange IV release studies from SF-MPs
Orange IV loaded SF-MPs and control samples (total volume
of 2 mL) were placed in a dialysis bag (cellulose membrane,
MWCO 12–14 kDa) that was sealed and immersed in 10 mL of
deionized water, with continuous magnetic stirring (200 rpm)
at room temperature for 6 days. At determined time intervals,
dialysis volume was withdrawn, quantified (n= 3), and replaced
with deionized water. Free orange IV (87 μM) dissolved in 10
g/L of SF solution and in deionized water was also placed in a
dialysis bag and used as control.
2.2.3.6 3D simulations
The 3D simulations were performed with the GROMACS 4.6
[42] package using the GROMOS force field. Initially, the pro-
tein was centered in the box and the orange IV molecules were
randomly distributed in the simulation box. The system size
was chosen according to the minimum image convention, tak-
ing into account a cutoff of 1.4 nm. The bonds lengths of the
proteins were constrained with LINCS [43] and those for wa-
ter with SETTLE [44]. Nonbonded interactions were calculated
using a twin-range method, with short and long range cutoffs
of 0.8 and 1.4 nm, respectively. Neighbor searching was carried
out up to 1.4 nm and updated every five steps. A time step of
integration of 2 fs was used. A reaction field correction for the
electrostatic interactions was applied using a dielectric constant
of 54 [45]. The single point chargemodel [46] was used for water
molecules. The initial systems were energy minimized for 2000
steps using the steepest descent method, with all heavy atoms
harmonically restrained using a force constant of 1000 kJ/mol
nm2. The systems were initialized in the canonical ensemble
(NVT) for 50 ns, with all heavy atoms harmonically restrained
using a force constant of 1000 kJ/mol nm2. The simulation was
then continued for 50 ns in the isothermal-isobaric ensemble
(NPT), with the heavy atoms harmonically restrained with the
same force constant. Finally, for allowing the equilibration of
the system properties, the simulations were further extended in
the NPT ensemble with positional restrains applied to the Cα
atoms. Pressure control was implemented using the Berendsen
barostat [47], with a reference pressure of 1 bar, 0.5 ps of re-
laxation time, and isothermal compressibility of 4.5 × 105 bar.
Temperature control was set using the V rescale [47,48] thermo-
stat at 300K. The protein and the solventmoleculeswere coupled
in separated heat baths, with temperatures coupling constants
of 0.025 ps in the first two initialization steps and with 0.1 ps for
the rest of the simulations. The simulation was carried out for
10 ns.
3 Results and discussion
3.1 SF-ME formation
The SF microparticles (SF-MPs) were produced by high-energy
emulsification using high-pressure homogenization method. In
this process, the ME formation and, consequently, the MP as-
sembly are owed to the action of high-energy disruptive forces,
namely, the hydraulic shear, intense turbulence, and cavita-
tion [17]. Due to these forces’ involvement, along this process
SF protein may suffer conformational changes [12, 17, 49].To
better understand the mechanisms involved in the HPH emul-
sification, the SF secondary structure of the developed SF-MEs
was evaluated by FTIR; the obtained results are presented in
Fig. 1.
According to Fig. 1A, the SF-MPs presented higher signal for
β-sheets, suggesting this secondary structure is dominant in this
sample, wherein the SF solution (before HPH emulsification)
presented high signal for random coil in amide I. Since Amide I
band (1600 and 1700 cm−1) is considered the most prominent
and sensitive vibrational band [50, 51], and its spectrum is not
significantly affected by side chain vibration [52], deeper analy-
sis was conducted through Gaussian deconvulation. The results
obtained according to the deconvulation of Amide I, namely,
SF content in β-sheets, β-turns, random coil, and 310-helix, are
presented in Fig. 1B. As it can be seen in Fig. 1B, SF subjected
to the HPH process increased the percentage of β-sheets. The
native conformation of SF has approximately 40% of β-sheets,
while SF-MEs show approximately 65% of β-sheet content. On
the other hand, the random-coil content slightly decreased from
25 to21%, respectively. These results suggest that the forces
involved in the HPH method lead SF to acquire a more stable
conformation, by increasing the crystalline structure of β-sheets.
The results obtained are in accordance with the literature
[12,21,23,53], where it is described that SF particles prepared by
mechanical mixing and self-assembly process are predominantly
composed by β-sheets. The formation of β-sheets increases en-
capsulation efficiency of small molecules and enables a tight
control of the release kinetics [12, 13]. Therefore, the developed
system is ideal for biomedical applications, such as drug delivery.
The use of emulsification processes in SF solutions, associated
to the enrichment of β-sheet content in the protein, usually
promotes the formation of spherical particles [12, 19, 54].
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Figure 1. (A) FTIR spectra of SF protein before and after HPH emulsification. (B) Results from the deconvulation of amide I region (1600
and 1700 cm−1) of SF protein before and after HPH emulsification process.
Particularly, Silva et al. [21] have observed by STEM the mor-
phology of SF-MPs produced by sonochemical emulsification
and described a spherical shape with smooth surfaces. The
authors also highlight that particles with spherical morphology
provide minimum contact with the aqueous environment and
longer diffusion transport, thus allowing efficient entrapment
of drugs and higher controlled release over time [21].
Despite that n-dodecane can cause cytotoxicity (according
to manufacturer’s product data sheet), previous work done by
our research group showed that only high ratios of n-dodecane
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Table 1. Yield of SF-MPs produced by high-pressure homogeniza-
tion according to the efficiency of formation in percentage
SF-MP yield efficiency
Sample of formation (%)
SF-MPs (control) 60.1 ± 3.0
SF-MPs with Tween 80 26.5 ± 4.8
SF-MPs with Transcutol 60.9 ± 3.3
SF-MPs with SDS 76.3 ± 2.0
SF-MPs with Orange IV 74.9 ± 3.5
(above 40%) were considered toxic in the human cell line RKO
(unpublished data and [21, 23]). Although a proven absence
of toxicity can only be evaluated with direct tests to evaluate
the SF-ME effect on cells, we may predict that the formulations
produced in this study should be biocompatible andwill not lead
to cytotoxicity due to n-dodecane. SF-MPs produced by HPH
emulsification with an efficiency formation of 60% (Table 2)
presented a small mean diameter (140.7 ± 1.9 nm) with an
acceptable PDI of 0.25 (Fig. 2A and B).
Table 2. Orange IV incorporation yield into SF-MPs produced by
high-pressure homogenization according to formation and en-
capsulation efficiencies in percentage
SF-MPs yield
formation
SF-MPs
encapsulation
Sample efficiency (%) efficiency (%)
SF-MPs with 50 μM of
Orange IV
74.9 ± 3.5 26.5 ± 0.7
SF-MPs with 75 μM of
Orange IV
72.3 ± 2.1 83.1 ± 1.4
SF-MPs with 100 μM of
Orange IV
66.9 ± 2.1 91.4 ± 0.1
3.1.1 SF-ME stability studies
Despite the successful formation of SF-MPs, the size and size
distribution of the obtained MPs were stable only for 2 wk. As
presented in Fig. 2A and B, SF-MP size and size distribution
values increased significantly at the second week. These findings
clearly demonstrate the need to incorporate a stabilizer into
Figure 2. Evaluation of the
stability of SF-MPs pro-
duced by high-pressure ho-
mogenization according to
(A) mean diameter in
nanometers (nm); (B) PDI
values, over several weeks;
and (C) zeta-potential de-
termination in millivolts
(mV) at the time of produc-
tion. Error bars represent
means ± SD of three inde-
pendent experiments.
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Figure 3. Representation of SF in 80/20 v/v mixture of water/n-
dodecane with incorporation of orange IV molecules. SF protein
is presented in green, evidencing the β-sheets, and the sticks
structures represent 17 molecules of orange IV interacting with
the SF structure. Portion of n-dodecane is not shown to facilitate
visualization.
the SF-ME formulation. Therefore, poloxamer 407, Tween 80,
transcutol, and SDS were tested.
As shown in Fig. 2A and B, the incorporation of the sur-
factants Tween 80, SDS, and transcutol into the formulation
increased the stability over time of the SF-MP mean diameter
and PDI in comparison to the SF-MPs without stabilizers (con-
trol). The effect of these compounds on the SF-MP stability
was further reflected on their high absolute zeta-potential values
(Fig. 2C). In detail, our interpretation of the zeta-potential val-
ues was done according to the Riddick’s Zeta-Meter [57, 58].
As described in the literature [55, 56], higher absolute values of
zeta potential (over ±25 mV) predict the formation of stable
emulsions. Charge with high absolute values (negative or pos-
itive) increases the electrostatic repulsion of other molecules,
and consequently prevents unstable events such as agglomera-
tion and flocculation to occur [55, 56]. However, the stability of
a suspension cannot be estimated only by zeta-potential mea-
surements [57,58]. Hence, in our work, this parameter was used
only as a complemental indicator, whereas size and PDI mea-
surements over time were more effective in the assessment of the
formulations’ stability.
Regarding poloxamer 407, its addition into the formulation
did not significantly improve the SF-MP properties in terms of
size (Fig. 2 A) and size distribution (Fig. 2B) over time, this
further being corroborated by the low zeta-potential absolute
values (Fig. 2C). These results were unexpected, since previous
studies showed the high stability improvement of BSAMEs [59].
We, then, suggest that the inability of poloxamer 407 to stabilize
the SF-MPs might be related to the number of propylene oxide
chains present in the formulation (0.33%).At this concentration,
the number of propylene oxide chains may not be enough to
effectively influence the particles’ stability [24]. Therefore, it is
predictable that an increase of poloxamer 407 concentration
should enhance the MP stability [24]. However, incorporation
of poloxamer 407 into the formulation at a higher concentration
is not advisable since this compound is considered by FDA as
slightly irritant [25]. Therefore, poloxamer 407 was considered
a nonefficient stabilizer for SF-MPs, and consequently discarded
from all formulations.
Formulationswith transcutol presented the smallest variation
in the mean diameter and PDI values (Fig. 2A and B). These
results suggest that transcutol is involved in SF-MP stabilization
by inducing the deposition of SF molecules around the oil [32,
33]. Besides the ability of transcutol to stabilize the SF-MPs,
this compound is known to enhance drug permeation through
skin/epidermis, making it suitable for topical and transdermal
delivery applications [31].
SDS addition to the formulation also showed great stabiliz-
ing effect on the SF-MPs, this being more evident in the PDI
values (Fig. 2B) and in the zeta-potential measurements (Fig.
2C). In fact, the highest SF-MP formation efficiency (76%)
was obtained using SDS (Table 1). These results suggest that
the gelling capacity of SDS leads SF protein to be organized
around oil droplets, creating MPs with a stronger conforma-
tion [29]. According to Wu et al.’s studies, SDS prevents coa-
lescence and flocculation to occur [29]. As described by these
authors, high SDS concentration leads to strong hydrophobic
forces and electrostatic effect triggering SF to self-assemble into
stable β-sheets [29].
3.1.2 Orange IV as stabilizer of SF-MPs
Although not considered a typical surfactant, in this work, we
assessed the effect of orange IV used as a model compound for
incorporation studies, on the stabilization of the SF-MP formu-
lation. According to Fig. 2A and B, the incorporation of orange
IV enhanced the stabilization of the particles over time. Once
again, this result was corroborated by the high absolute value
of zeta potential (Fig. 2C). Additionally, the incorporation of
orange IV increased the efficiency of SF-MP formation to 75%
(Table 1).
To our knowledge, this is the first time that this stabilizing
ability of orange IV is reported. The orange IV ability to stabilize
the SF-MPs is probably due to the establishment of hydrophobic
interactions and van der Waals forces with SF protein by the
azo (N = N) and sulfonic groups (S = O) [38, 60]. In addition,
this stabilization effect may also be related to the dye ability
to increase gelation of SF solutions, since gelation increases the
emulsion stability over time [60,61]. A similar phenomenonwas
suggested by Xiao et al. [60], corroborating our hypothesis that
the stabilization effect of orange IV is related to the ability of SF
to adsorb dyes. As an acidic dye, orange IV dissolution in the
SF solution decreases pH and causes SF protonation, reducing
the repulsion and consequently enabling the SF-MP stabilization
[60, 61]. This is also, validated by Xiao et al.’s studies, in which
they demonstrated that the pH highly influences the interaction
effects between SF protein and dyes [60].
Our FTIR results of SF-MPs loaded with 1% of orange
IV (Fig. 1B) corroborated the findings that the incorporation
of the dye stabilizes the SF-MP structure. The dyed particles
have the highest content of β-sheets and the lowest content of
random-coil structure compared to SF solution and SF-MPs
without orange IV. These results suggest that the maintainability
of SF-MP size and size distribution might be related to the
structural interactions between orange IV and SF. To illustrate
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Figure 4. Evaluation of the
stability of orange IV loaded
SF-MPs, produced by high-
pressure homogenization, ac-
cording to (A) mean diam-
eter in nanometers (nm);
(B) PDI values, over several
weeks; and (C) zeta-potential
determination in millivolts
(mV) at the time of production.
Error bars represent means ±
SD of three independent exper-
iments.
our discussion, a representative image (Fig. 3) of the orientation
of SF protein and orange IVmolecules in anMEwas designed to
better understand the interaction between the two compounds.
In this simulation, due to the high dimension (MW, 39 kDa) and
characteristic repetitive domains ([Gly-Ala-Gly-Ala-Gly-Ser]n)
of SF protein, only a fragment of the SF repetitive arrangement
is demonstrated. The orange IV molecules seem to have
the ability to interact with the SF protein, leading to their
entrapment in the protein structure. However, this behavior is
somewhat unclear to us, and this system should be subjected to
deeper studies. The combination of these results with the data
concerning size measurements, PDI, and zeta potential support
the previously stated stabilizing effect of orange IV on SF-MPs.
3.2 Orange IV as a model compound for
incorporation and release analysis
Orange IV dye can be used as model for incorporation and drug
release studies. In order to determine the maximum concen-
tration of the dye to be incorporated without disturbing the
stability of the MPs, several concentrations of orange IV were
tested. In these assays, no additional stabilizers were added to
the formulations.
Considering the results shown in Fig. 4A and B and Table 2,
the maximum concentration of orange IV that could be opti-
mally incorporated into the SF-MPs is 100 μM. At this con-
centration, we were able to obtain small particles (140 nm of
diameter) with an acceptable size distribution (PDI of 0.3) and
with high efficiencies of formation and encapsulation (67 and
91%, respectively). In addition, zeta-potential results (Fig. 4C)
corroborated the sample stability by the measured high absolute
zeta-potential value (−35 mV).
3.2.1 Orange IV release profile from SF-MPs
The release profile of orange IV incorporated into the SF-MPs
was accessed by dialysis over 6 days (Fig. 5). Controls were per-
formed dissolving the dye in water and in SF solution.
As it can be seen in Fig. 5, the free dye shows a fast diffusion
rate in the first 18 h, 78.0 ± 1.4% being recovered in the dialysis
water. Then it follows a slower rate, with 92.6 ± 4.8% of the dye
beingmeasured after 48 h, and on the sixth day of dialysis 99.6±
0.1% of the initial amount was quantified. The release of orange
IV from SF-MPs follows the same trend although with lower
amount of dye being recovered on the dialysis water. Hence, we
measured a fast release of 39.4± 0.9%during the first 18 h,which
increased around 10%after 48 h to an orange IV release of 48.2±
0.9%. At this time point, the formulation stabilized and nomore
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Figure 5. Orange IV release
studies from SF-MPs incorpo-
rated with 100 μM of orange
IV. Orange IV dissolved in wa-
ter and in regenerated silk fibroin
(RSF) solution was used as con-
trol. Error bars represent means
± SD of three independent
experiments.
dye was released (49.4± 0.9% on day 6). As suggested previously
(Fig. 3), orange IV is incorporated in the SF-MPs by interaction
with SF β-sheets. Thus, it is expected that a fraction of the dye
should be held into the MPs, and will only be released after the
disruption of the particles. This assumption is also supported
by the fact that, in the presence of SF in solution (Fig. 5), a fast
release of 56.0± 1.1%wasmeasured after 18 h of incubation and
the maximum of orange IV recovery was reached at 48 h (76.2±
2.5%) without any further increase in the diffusion over 6 days
of incubation (79.0 ± 2.5%). That is, SF itself has the ability to
hold 20% of the dye, data that go in agreement with Xiao et al.’s
findings of SF adsorption ability [60]. Additionally, these results
also agreewith previous suggestions about the capacity of orange
IV in increasing SF gelation [60, 61].
The release of the incorporated orange IV from the SF-MPs
was 1.5 and 2 times slower than the release of the dye from dif-
fusion in the presence and absence of SF, respectively. Hence, the
SF-MPs produced by HPH emulsification can incorporate and
retain the orange IV in their structure and enable a slower and
controlled release over time. Taking into account the previous
results that orange IV possesses a greater stabilizer effect than
traditional stabilizers, it is important to consider its use asmodel
compound for drug incorporation and release studies, as its ad-
dition to the formulation is not inert. Our findings show that
orange IV can influence the particles properties and can lead to
misinterpretations of the results. The phenomenon described in
this work is important as it can be considered as an innovative
method to control molecules entrapment and release in formu-
lations, since the presence of orange IV in SF-MPs yields stable
particles over 3 wk (Fig. 2A and B).
4 Concluding remarks
Along the SF-ME production by HPH emulsification, the SF
secondary structure changed from random coil to β-sheets. As
the presence of β-sheets confers a more stable conformation, it
is possible to produce small and stable SF-MPs (140.7 ± 1.9 nm;
PDI of 0.25) with a formation efficiency of 60%.
Even so, the stability of SF-MP size and size distribution over
time can be further improved by the incorporation of surfac-
tants, such as transcutol. The incorporation and release studies
using orange IV dye allowed us to discover a new application.
According to our knowledge, this is the first time that the stabi-
lizing effect of orange IV is described in SF-MPs. In our work,
it is suggested that this effect might be related to orange IV azo
(N = N) and sulphonic groups (S = O) that interact with SF
protein, as illustrated in 3D simulation. These findings draw at-
tention and concern the use of dyes as model compounds for
incorporation and drug release studies, since the addition of
dyes to formulations can influence the particles properties and
mislead the interpretation of results.
The biocompatibility, stability, and controlled entrapment
and release of these new developed SF-MPs have enhanced po-
tential for biomedical applications, such as drug delivery with
controlled release.
Practical application
The highlights of this work are as follows:
 Amicroemulsion (ME) of silk fibroin (SF) can be assem-
bled by oil-in-water emulsification using high-pressure
homogenization.
 The β-sheet content of SF protein increases during the
ME production process.
 Orange IV has a strong stabilizing effect on SF-MEs.
The new preparation technique of SF-MEs presented
here could be easily scaled up. SF is biocompatible, and
the prepared MEs are stable and effective in cargo release.
Therefore, the SF-MEs could be applied as a drug delivery
system.
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